Two Sigma Advisers
DWTX

Two Sigma Advisers’s Dogwood Therapeutics DWTX Stock Holding History

Two Sigma Advisers’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-576
Closed -$65K – 2917
2022
Q1 		$65K Sell
576
-4
-0.7% -$582 ﹤0.01% 2559
2021
Q4 		$74K Sell
580
-556
-49% -$70.7K ﹤0.01% 2444
2021
Q3 		$150K Buy
1,136
+148
+15% +$20.5K ﹤0.01% 2294
2021
Q2 		$155K Sell
988
-496
-33% -$70.3K ﹤0.01% 2299
2021
Q1 		$213K Buy
+1,484
New +$258K ﹤0.01% 2343

Other funds holding DWTX

MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CA
Cetera Advisors Denver, Colorado $12.7B AUM 22.7% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.88B AUM 29.07% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return

Two Sigma Advisers's DWTX Position: Q2 2022 in Review

Two Sigma Advisers sold out of Dogwood Therapeutics (DWTX) in Q2 2022, closing a stake of 576 shares — an estimated $65K sold.

Two Sigma Advisers first reported a position in DWTX in Q1 2021 and held it in 5 quarters. The position peaked at $213K in Q1 2021. 17 funds tracked by Wall St. Rank hold DWTX as of Q2 2022.

  • Two Sigma Advisers reported no remaining Dogwood Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 576 Dogwood Therapeutics shares in Q2 2022, an estimated $65K.
  • Two Sigma Advisers first reported a position in Dogwood Therapeutics in Q1 2021 and held it in 5 quarters.
  • Two Sigma Advisers's Dogwood Therapeutics position peaked at $213K in Q1 2021.
  • 17 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q2 2022.

Based on Two Sigma Advisers's 13F filing for Q2 2022, filed 15 Aug 2022.